Diadema Partners »

Bicycle Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 476k 4.64

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Fcpm Iii Services B.v.
Armistice Capital
Long Focus Capital Management
Acadian Asset Management
Siren
Principal Financial Group
Renaissance Technologies
Morgan Stanley
Schroder Investment Management Group
Diadema Partners
Birchview Capital
Silvercrest Asset Management Group
Citadel Advisors
Marshall Wace

View all funds holding Bicycle Therapeutics